Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01541748 · ClinicalTrials.gov registry record

Axis™ Allograft Dermis for Female Pelvic Floor Repair: a Prospective Post Market Study

A clinical trial of Pelvic Organ Prolapse, sponsored by Coloplast A/S.

Completed
Registry status
74
Enrollment target
5
Study locations

NCT01541748: Completed study of Pelvic Organ Prolapse, sponsored by Coloplast A/S.

NCT01541748 is a study of Pelvic Organ Prolapse that has completed, run by Coloplast A/S. The registered enrollment target is 74 participants, below the 143-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (48% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01541748, a study of Pelvic Organ Prolapse, has completed, sponsored by Coloplast A/S.

COMPLETED
Registry status
74 participants
Enrollment target
5
Study locations

Study Summary

This study is a prospective, single arm, multi-center, post-market study to evaluate the efficacy of Axis™ Allograft Dermis used for anterior, posterior or combined (anterior and posterior) pelvic organ prolapse repair.

Primary Outcome

The Pelvic Organ Prolapse Quantification system (POP-Q) is used to measure pelvic organ prolapse. POP-Q Stages are: Stage 0: No prolapse is demonstrated Stage 1: The criteria for stage 0 are not met, but the most distal portion of the prolapse is greater than 1 cm above the level of the hymen Stage 2: The most distal portion of the prolapse is greater than or equal to 1 centimeter proximal to or distal to the plane of the hymen Stage 3: The most distal portion of the prolapse is greater than 1

Conditions Studied

Interventions

  • OTHER Axis

Study Locations (5)

Pennsylvania

  • The Institute for Female Pelvic Medicine and Reconstructive Surgery - Allentown
  • Philadelphia Urosurgical Associates - Philadelphia

Florida

  • Cleveland Clinic Florida - Weston

Massachusetts

  • Boston Urogynecology Associates - Cambridge

Michigan

  • Female Pelvic Medicine and Urogynecology Institute of MI/Grand Rapids Women's Health - Grand Rapids

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2011-11
Est. Completion 2018-11-11
Coloplast A/S

21 total trials

What the finished NCT01541748 record still lists

NCT01541748 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 143-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (48% lower).

The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 1 intervention - of which Axis is the first listed.

NCT01541748 lists 5 locations in 4 states (Pennsylvania, Florida, Massachusetts).

Frequently Asked Questions

What is clinical trial NCT01541748 about?

NCT01541748 is a clinical study titled "Axis™ Allograft Dermis for Female Pelvic Floor Repair: a Prospective Post Market Study". This study is a prospective, single arm, multi-center, post-market study to evaluate the efficacy of Axis™ Allograft Dermis used for anterior, posterior or combined (anterior and posterior) pelvic organ prolapse repair.

What is the current status of trial NCT01541748?

This trial is currently completed. The enrollment target is 74 participants. The study started on 2011-11. Estimated completion is 2018-11-11.

What conditions does trial NCT01541748 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse.

What interventions are being tested in trial NCT01541748?

The interventions under investigation include: Axis (OTHER).

Who is sponsoring clinical trial NCT01541748?

This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01541748 being conducted?

This trial has 5 study locations across Florida, Massachusetts, Michigan, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01541748's enrollment target sits among peer trials

74 28th of 40 higher than 13 of 40 other Pelvic Organ Prolapse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01541748, the US trial registry maintained by the National Library of Medicine. NCT01541748 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.